Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

1.

[Research progress of role of cannabinoid receptor in fibrosis].

Li S, Wang L, Liu M, Gao Y, Tian Z, Jiang S, Zhang M, Guan D.

Zhonghua Bing Li Xue Za Zhi. 2014 Feb;43(2):136-8. Chinese. No abstract available.

PMID:
24742582
[PubMed - in process]
2.

Cannabinoids reduce markers of inflammation and fibrosis in pancreatic stellate cells.

Michalski CW, Maier M, Erkan M, Sauliunaite D, Bergmann F, Pacher P, Batkai S, Giese NA, Giese T, Friess H, Kleeff J.

PLoS One. 2008 Feb 27;3(2):e1701. doi: 10.1371/journal.pone.0001701.

PMID:
18301776
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Cannabinoid receptor type I modulates alcohol-induced liver fibrosis.

Patsenker E, Stoll M, Millonig G, Agaimy A, Wissniowski T, Schneider V, Mueller S, Brenneisen R, Seitz HK, Ocker M, Stickel F.

Mol Med. 2011;17(11-12):1285-94. doi: 10.2119/molmed.2011.00149. Epub 2011 Aug 19.

PMID:
21863215
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system.

Lazzerini PE, Natale M, Gianchecchi E, Capecchi PL, Montilli C, Zimbone S, Castrichini M, Balistreri E, Ricci G, Selvi E, Garcia-Gonzalez E, Galeazzi M, Laghi-Pasini F.

J Mol Med (Berl). 2012 Mar;90(3):331-42. doi: 10.1007/s00109-011-0824-5. Epub 2011 Oct 28.

PMID:
22033526
[PubMed - indexed for MEDLINE]
5.

CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis.

Teixeira-Clerc F, Julien B, Grenard P, Tran Van Nhieu J, Deveaux V, Li L, Serriere-Lanneau V, Ledent C, Mallat A, Lotersztajn S.

Nat Med. 2006 Jun;12(6):671-6. Epub 2006 May 21.

PMID:
16715087
[PubMed - indexed for MEDLINE]
6.

Cannabinoid receptors as therapeutic targets for dialysis-induced peritoneal fibrosis.

Yang CY, Chau YP, Lee HT, Kuo HY, Lee OK, Yang AH.

Am J Nephrol. 2013;37(1):50-8. doi: 10.1159/000345726. Epub 2013 Jan 4.

PMID:
23296044
[PubMed - indexed for MEDLINE]
7.

Cannabinoid receptors and the regulation of immune response.

Berdyshev EV.

Chem Phys Lipids. 2000 Nov;108(1-2):169-90. Review.

PMID:
11106790
[PubMed - indexed for MEDLINE]
8.

Endocannabinoids anandamide and its cannabinoid receptors in liver fibrosis after murine schistosomiasis.

Liu H, Gao X, Duan R, Yang Q, Zhang Y, Cheng Y, Guo Y, Tang W.

J Huazhong Univ Sci Technolog Med Sci. 2009 Apr;29(2):182-6. doi: 10.1007/s11596-009-0209-y. Epub 2009 Apr 28.

PMID:
19399401
[PubMed - indexed for MEDLINE]
9.

Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy.

Rajesh M, Bátkai S, Kechrid M, Mukhopadhyay P, Lee WS, Horváth B, Holovac E, Cinar R, Liaudet L, Mackie K, Haskó G, Pacher P.

Diabetes. 2012 Mar;61(3):716-27. doi: 10.2337/db11-0477. Epub 2012 Feb 7.

PMID:
22315315
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Cannabinoid receptors and their endogenous agonists.

Felder CC, Glass M.

Annu Rev Pharmacol Toxicol. 1998;38:179-200. Review.

PMID:
9597153
[PubMed - indexed for MEDLINE]
11.

Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats.

Muñoz-Luque J, Ros J, Fernández-Varo G, Tugues S, Morales-Ruiz M, Alvarez CE, Friedman SL, Arroyo V, Jiménez W.

J Pharmacol Exp Ther. 2008 Feb;324(2):475-83. Epub 2007 Nov 20.

PMID:
18029545
[PubMed - indexed for MEDLINE]
Free PMC Article
12.
13.

Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review.

Svízenská I, Dubový P, Sulcová A.

Pharmacol Biochem Behav. 2008 Oct;90(4):501-11. doi: 10.1016/j.pbb.2008.05.010. Review.

PMID:
18584858
[PubMed - indexed for MEDLINE]
14.

Cannabinoid receptor genes.

Onaivi ES, Chakrabarti A, Chaudhuri G.

Prog Neurobiol. 1996 Mar-Apr;48(4-5):275-305. Review.

PMID:
8804112
[PubMed - indexed for MEDLINE]
15.

The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis.

Akhmetshina A, Dees C, Busch N, Beer J, Sarter K, Zwerina J, Zimmer A, Distler O, Schett G, Distler JH.

Arthritis Rheum. 2009 Apr;60(4):1129-36. doi: 10.1002/art.24395.

PMID:
19333940
[PubMed - indexed for MEDLINE]
Free Article
16.

The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.

Fride E.

Neuro Endocrinol Lett. 2004 Feb-Apr;25(1-2):24-30. Review.

PMID:
15159678
[PubMed - indexed for MEDLINE]
17.

Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPgammaS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide.

Romero J, Berrendero F, García-Gil L, Lin SY, Makriyannis A, Ramos JA, Fernández-Ruiz JJ.

Neurochem Int. 1999 Jun;34(6):473-82.

PMID:
10402222
[PubMed - indexed for MEDLINE]
18.

The direct profibrotic and indirect immune antifibrotic balance of blocking the cannabinoid 2 receptor.

Avraham Y, Amer J, Doron S, Abu-Tair L, Mahamid M, Khatib A, Berry EM, Safadi R.

Am J Physiol Gastrointest Liver Physiol. 2012 Jun 15;302(12):G1364-72. doi: 10.1152/ajpgi.00191.2011. Epub 2012 Apr 19.

PMID:
22517772
[PubMed - indexed for MEDLINE]
Free Article
19.

Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity.

Tam J, Godlewski G, Earley BJ, Zhou L, Jourdan T, Szanda G, Cinar R, Kunos G.

Am J Physiol Endocrinol Metab. 2014 Feb 15;306(4):E457-68. doi: 10.1152/ajpendo.00489.2013. Epub 2013 Dec 31.

PMID:
24381003
[PubMed - indexed for MEDLINE]
20.

Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis.

Servettaz A, Kavian N, Nicco C, Deveaux V, Chéreau C, Wang A, Zimmer A, Lotersztajn S, Weill B, Batteux F.

Am J Pathol. 2010 Jul;177(1):187-96. doi: 10.2353/ajpath.2010.090763. Epub 2010 May 27.

PMID:
20508030
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk